Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brooke

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Nature Microbiology|April 28, 2022
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Open Forum Infectious Diseases|July 6, 2022
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue DistributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Journal of Virology|February 9, 2024
Correction for Rasmussen et al., "Virology-the path forward"Angela L Rasmussen, Gigi K Gronvall, Anice C Lowen, et al.
Journal of Virology|January 3, 2024
Virology-the path forwardAngela L Rasmussen, Gigi K Gronvall, Anice C Lowen, et al.
Nature Communications|June 10, 2022
Mitigation of SARS-CoV-2 transmission at a large public universityDiana Rose E Ranoa, Robin L Holland, Fadi G Alnaji, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Nature Microbiology|April 28, 2022
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Open Forum Infectious Diseases|July 6, 2022
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue DistributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Journal of Virology|February 9, 2024
Correction for Rasmussen et al., "Virology-the path forward"Angela L Rasmussen, Gigi K Gronvall, Anice C Lowen, et al.
Journal of Virology|January 3, 2024
Virology-the path forwardAngela L Rasmussen, Gigi K Gronvall, Anice C Lowen, et al.
Nature Communications|June 10, 2022
Mitigation of SARS-CoV-2 transmission at a large public universityDiana Rose E Ranoa, Robin L Holland, Fadi G Alnaji, et al.
Pageof 9